Annual whole-body, low-dose computed tomography (WBLDCT) can improve the management of smoldering multiple myeloma (SMM), ...

Munich news, health insurance, technology, jobs and other topics for expatriates. The Eye Newspapers covers daily news and offers services for foreigners.

[80] Bone disease is a hallmark of multiple myeloma (MM), associated with bone ... Osteolytic bone lesions are the result of excessive bone resorption due to increased osteoclast formation and ...

30 210 338 1540 Fax: +30 210 338 1511 Bone disease is a hallmark of multiple myeloma (MM), associated ... Osteolytic bone lesions are the result of excessive bone resorption due to increased ...

Q1 2025 Earnings Call Transcript April 15, 2025 Johnson & Johnson beats earnings expectations. Reported EPS is $2.77, ...

New Innovative Local Treatment for Osteolytic Bone Disease in Multiple Myeloma Jan. 14 ... with high potential in in the treatment of bone lesions or minimal residual disease in multiple ...

2025 — A team of researchers has developed a new biomaterial with high potential in in the treatment of bone lesions or minimal residual disease in multiple myeloma patients. The findings showcase a ...

Blenrep is the only anti-BCMA (B-cell maturation antigen) antibody-drug conjugate (ADC) therapy for multiple myeloma, offering a new mechanism of action for patients at or after relapse.

The UK's Medicines and Healthcare products Regulatory Agency (MHRA) has authorised GSK’s Blenrep for treating multiple ...

Elevated fibrinogen levels can contribute to a hypercoagulable state by increasing blood viscosity, red blood cell red blood cell and platelet aggregation, and platelet activity, reducing blood flow ...

HIGHER lesion burden in the uncinate fasciculus (UF), a key brain pathway linking emotional regulation regions, is associated with increased anxiety severity in multiple sclerosis (MS) patients, ...

Researchers sought to evaluate preferences related to treatment features of BCMA-directed bispecific antibodies and CAR-T therapy.